Table 3.

Biopsy Adverse Events – Pre-2018 vs. Post-2018 Technique.

Documented Biopsy Procedure Follow-up, n (%) 89/95 (93.7)	Pre-2018 (71/89)	Post-2018 (18/89)
Pain 1–3 (/10) (Greater than normal post-operative pain/discomfort)	16 (22.5)	5 (27.8)
Pain 3–6 (/10) (Greater than normal post-operative pain/discomfort)	10 (14.1)	0
Pain 6–10 (/10) (Greater than normal post-operative pain/discomfort)	3 (4.2)	0
Transient Neuropathy	4 (5.6)	0
Hematoma	4 (5.6)	0
Allergic reactions, gastrointestinal disturbances, and photosensitivity secondary to declomycin intake	2 (2.8)	1 (5.6)
Seroma	1 (1.4)	0
Skin Site Infection (Cellulitis)	1 (1.4)	1 (5.6)
Fracture (Biopsy Site)	1 (1.4)	0